MARKET

BCTXZ

BCTXZ

Briacell Therapeutics Corp
NASDAQ
0.4100
0.0000
0.00%
Closed 09:30 12/04 EST
OPEN
0.4100
PREV CLOSE
0.4100
HIGH
0.4100
LOW
0.4100
VOLUME
0
TURNOVER
--
52 WEEK HIGH
1.515
52 WEEK LOW
0.1200
MARKET CAP
--
P/E (TTM)
-0.0066
1D
5D
1M
3M
1Y
5Y
1D
BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025
Barchart · 11/25 06:30
BRIACELL AND RECEPTOR.AI TO COLLABORATE ON AI DRIVEN SMALL MOLECULE CANCER THERAPEUTICS
Reuters · 11/20 12:30
BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025
Barchart · 11/18 06:30
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025
Barchart · 11/07 06:30
BRIACELL RECEIVES POSITIVE RECOMMENDATION FROM DATA SAFETY MONITORING BOARD (DSMB) FOR PHASE 3 STUDY IN METASTATIC BREAST CANCER
Reuters · 10/22 11:30
BRIACELL THERAPEUTICS CORP: POST REVIEW, DSMB RAISED NO SAFETY CONCERNS & RECOMMENDED STUDY CONTINUE WITHOUT MODIFICATIONS
Reuters · 10/22 11:30
BRIACELL ANNOUNCES COLLABORATION WITH MSK ACCELERATOR TO ADVANCE BRIA-OTS+™ FOR BREAST CANCER
Reuters · 10/21 11:30
BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study
Barchart · 10/21 06:50
More

Webull offers Briacell Therapeutics Corp stock information, including NASDAQ: BCTXZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTXZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCTXZ stock methods without spending real money on the virtual paper trading platform.